Kirsten M J Thompson1, J Joseph Speidel, Vicki Saporta, Norma Jo Waxman, Cynthia C Harper. 1. Bixby Center for Global Reproductive Health, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, School of Medicine, UCSF Box 0744, San Francisco, CA 94143, USA. thompsonkm@obgyn.ucsf.edu
Abstract
BACKGROUND: Placement of long-acting reversible contraceptives (LARC) - intrauterine devices (IUDs) and the implant - directly after an abortion provides immediate contraceptive protection and has been proven safe. STUDY DESIGN: We conducted a survey of National Abortion Federation member facilities (n=326; response rate 75%) to assess post-abortion contraceptive practices. Using multivariable logistic regression, we measured variations in provision of long-acting contraception by clinic factors and state contraceptive laws and policies. RESULTS: The majority (69%) of providers surveyed offered long-acting methods, but fewer offered immediate post-abortion placement of intrauterine devices (36%) or implants (17%). Most patients were provided with contraception; 6.6% chose LARC methods offering the highest level of protection. Post-abortion provision of these methods was lower in stand-alone abortion clinics (p ≤.001), but higher with recent clinician training (p ≤.001) and in the absence of clinic flow barriers (p ≤.001). State policies had a significant impact on how women paid for contraception and the likelihood of LARC use. Patient use was higher in states with contraceptive coverage mandates (p ≤.01) or Medicaid family planning expansion programs (p ≤.05). CONCLUSIONS: Use of the most effective contraceptives immediately post-abortion is rare in the United States. State policies, high cost to patients, and the ongoing need for clinician training in the methods hinder provision and patient uptake. Contraceptive policies are an important component of abortion patient access to the most effective methods.
BACKGROUND: Placement of long-acting reversible contraceptives (LARC) - intrauterine devices (IUDs) and the implant - directly after an abortion provides immediate contraceptive protection and has been proven safe. STUDY DESIGN: We conducted a survey of National Abortion Federation member facilities (n=326; response rate 75%) to assess post-abortion contraceptive practices. Using multivariable logistic regression, we measured variations in provision of long-acting contraception by clinic factors and state contraceptive laws and policies. RESULTS: The majority (69%) of providers surveyed offered long-acting methods, but fewer offered immediate post-abortion placement of intrauterine devices (36%) or implants (17%). Most patients were provided with contraception; 6.6% chose LARC methods offering the highest level of protection. Post-abortion provision of these methods was lower in stand-alone abortion clinics (p ≤.001), but higher with recent clinician training (p ≤.001) and in the absence of clinic flow barriers (p ≤.001). State policies had a significant impact on how women paid for contraception and the likelihood of LARC use. Patient use was higher in states with contraceptive coverage mandates (p ≤.01) or Medicaid family planning expansion programs (p ≤.05). CONCLUSIONS: Use of the most effective contraceptives immediately post-abortion is rare in the United States. State policies, high cost to patients, and the ongoing need for clinician training in the methods hinder provision and patient uptake. Contraceptive policies are an important component of abortionpatient access to the most effective methods.
Authors: Cynthia C Harper; J Joseph Speidel; Eleanor A Drey; James Trussell; Maya Blum; Philip D Darney Journal: Obstet Gynecol Date: 2012-02 Impact factor: 7.661
Authors: Cynthia C Harper; Laura Stratton; Tina R Raine; Kirsten Thompson; Jillian T Henderson; Maya Blum; Debbie Postlethwaite; J Joseph Speidel Journal: Prev Med Date: 2013-10-12 Impact factor: 4.018
Authors: May Sudhinaraset; Dovile Vilda; Jessica D Gipson; Marta Bornstein; Maeve E Wallace Journal: Am J Prev Med Date: 2020-10-13 Impact factor: 5.043
Authors: Cynthia C Harper; Jillian T Henderson; Tina R Raine; Suzan Goodman; Philip D Darney; Kirsten M Thompson; Christine Dehlendorf; J Joseph Speidel Journal: Fam Med Date: 2012-10 Impact factor: 1.756
Authors: Kirsten M J Thompson; Corinne H Rocca; Lisa Stern; Johanna Morfesis; Suzan Goodman; Jody Steinauer; Cynthia C Harper Journal: Am J Obstet Gynecol Date: 2018-03-23 Impact factor: 8.661